|
|
Volumn , Issue , 2013, Pages
|
|
Treatment algorithms for hormone receptor-positive advanced breast cancer: going forward in endocrine therapy—overcoming resistance and introducing new agents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN RECEPTOR;
HISTONE DEACETYLASE INHIBITOR;
PROGESTERONE RECEPTOR;
PROTEIN KINASE INHIBITOR;
TUMOR MARKER;
ANIMAL;
BREAST NEOPLASMS;
DRUG DESIGN;
DRUG EFFECTS;
DRUG RESISTANCE;
FEMALE;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DRUG DESIGN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HISTONE DEACETYLASE INHIBITORS;
HUMANS;
MOLECULAR TARGETED THERAPY;
PROTEIN KINASE INHIBITORS;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84946237735
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e28 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|